| Trial ID: | L0766 |
| Source ID: | KCT0003554
|
| Associated Drug: |
Daesiho-tang
|
| Title: |
A study of Daesiho-tang on weight loss in Obese Patients with non-alcoholic fatty liver disease: a double-blind, placebo-controlled randomized clinical trial
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
;Endocrine, nutritional and metabolic disease
|
| Interventions: |
Drug : Oral administration of Daesiho-tang or placebo drug for 12 weeks, 3 times a day (3 grams at a time) before or between meals
|
| Outcome Measures: |
Body weightBody composition analysis (fat percentage, fat mass, muscle mass);anthropometric measurements (waist circumference, hip circumference);AST, ALT, gamma-GT;serum lipid concentrations;Fibroscan analysis (CAP score and LSM score);Quality of Life questionnaire;Intestinal microbial composition
|
| Sponsor/Collaborators: |
Dunsan Korean Medicine Hospital of Daejeon University
|
| Gender: |
All
|
| Age: |
19(Year)64(Year)
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional Study
|
| Study Designs: |
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
|
| Start Date: |
25/02/2019
|
| Completion Date: |
--
|
| Results First Posted: |
25/02/2019
|
| Last Update Posted: |
25 March 2019
|
| Locations: |
Korea, Republic of
|
| URL: |
http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=13379
|
